Prostate Cancer Patients With Germline Variants Were Often Not Covered by Testing Guidelines

NEW YORK (GenomeWeb) – Nearly 20 percent of men with prostate cancer harbor a germline variant that places them at increased risk of developing the disease, according to a new study, but a third of them were not eligible for genetic testing according to guidelines in place at the time.